中文

瑞迈特 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-28

瑞迈特 reported revenue of ¥0.76B for the period ended 2026-06-30, +40.3% year on year. Net income was ¥0.13B, a 17.1% net margin on a 53.3% gross margin. The largest revenue line is 家用呼吸诊疗产品 at 72% of the total. Free cash flow for the period was ¥0.09B.

ItemAmountY/Y
Revenue¥0.76B+40.3%
Gross profit¥0.41B
Operating income¥0.16B
Net income¥0.13B-2.7%
Gross margin53.3%Net margin 17.1%
Revenue Q/Q+46.9%

Revenue Segments

SegmentRevenueShare
家用呼吸诊疗产品¥0.55B71.7%
耗材产品¥0.20B26.8%
医用产品¥0.01B1.4%
其他(补充)¥0.00B0.0%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.36B46.7%
R&D¥0.06B8.1%
SG&A¥0.18B23.2%
Tax & other¥0.03B3.7%

Balance sheet & cash flow

ItemAmount
Total assets¥3.59B
Total liabilities¥0.51B
Shareholders' equity¥3.07B
Equity / assets85.6%
Operating cash flow¥0.10B
Capital expenditure¥0.01B
Free cash flow¥0.09B
Cash conversion (OCF / net income)102%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

丰立智能联动科技国科恒泰敷尔佳科净源凌玮科技致欧科技鼎泰高科通达海天山电子挖金客赛维时代

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies